Evidence map›Paper›PMID 39240125›Full record

SynthesisJournal of cosmetic dermatology2024

Meta-Analysis of the Efficacy of Intense Pulsed Light and Pulsed-Dye Laser Therapy in the Management of Rosacea.

Qianyu Zhai, Shaohang Cheng, Runying Liu, Jinying Xie, Xiao Han, Zhen Yu

Registry-linked trialAbstract readComparative StudyMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Journal of cosmetic dermatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07729540 (Intense Pulsed Light, a Targeted Anti-Redness Dermocosmetic Regimen, and Their Combination for Erythematotelangiectatic Rosacea), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07729540 nacompletednot on this mapstarted 2025, after this paper: background citation

Intense Pulsed Light, a Targeted Anti-Redness Dermocosmetic Regimen, and Their Combination for Erythematotelangiectatic Rosacea: A Comparative Study Using Antera 3D Chromophore Mapping, Grey-Level Co-Occurrence Matrix Texture Analysis and Clinician Erythema Assessment Scale.

TypeinterventionalSponsorMedical University of SilesiaRan2025 to 2026Enrolled60ConditionsRosaceaArmsIntense Pulsed Light (IPL) - Lumecca, Rosacure anti-redness dermocosmetic regimen
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Molecular Mechanisms in the Etiopathology of Rosacea-Systematic Review.International journal of molecular sciences · 2025
    Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Plant-derived extracellular vesicles in facial aesthetics.Extracellular vesicles and circulating nucleic acids · 2025
    Review
  10. A Case of Intense Pulsed Light Aggravated Rosacea Successfully Treated by Abrocitinib.Clinical, cosmetic and investigational dermatology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Qianyu ZhaiDepartment of Dermatology, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Shaohang ChengDepartment of Dermatology, Shenzhen People's Hospital, Shenzhen, Guangdong, China.
Runying LiuDepartment of Dermatology, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Jinying XieDepartment of Dermatology, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Xiao HanDepartment of Dermatology, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.
Zhen YuDepartment of Dermatology, Shenzhen Center for Chronic Disease Control, Shenzhen, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe primary aim of this systematic review and meta-analysis was to synthesize and compare the clinical efficacy of intense pulsed light (IPL) and pulsed-dye laser (PDL) therapies for the management of rosacea.

methodsThe literatures were searched in the Web of Science, PubMed, Embase, and Cochrane Library databases to identify relevant studies investigating the use of IPL and PDL for the treatment of rosacea. Screening of the retrieved articles and data extraction were performed as per the pre-established inclusion and exclusion criteria. The primary outcome measures evaluated in this meta-analysis included clearance rates, erythema scores, and pain scores.

resultsThe meta-analysis incorporated data from four studies involving a total of 141 participants. The meta-analysis did not reveal a statistically significant difference between IPL and PDL in the rate of achieving greater than 50% clearance (RR = -0.07, 95% CI: -0.19, 0.05). However, the IPL group demonstrated a significantly higher rate of clearance exceeding 75% compared to the PDL group (RR = -0.13, 95% CI: -0.23, -0.04). The change in erythema index, a key measure of rosacea severity, was similar between the two treatment modalities (SMD = -0.15, 95% CI: -0.55, 0.26). Interestingly, the PDL group reported a notably lower VAS pain score than the IPL group (SMD = 1.54, 95% CI: 0.08, 3.00).

conclusionEither PDL or IPL appears to be effective modalities for the management of rosacea. IPL exhibits a slight advantage in achieving a higher rate of substantial (>75%) clearance, while PDL may be preferable for patients with lower tolerance for post-treatment discomfort. However, the existing literature directly comparing these two laser/light-based therapies is limited, warranting further well-designed, large-scale studies to establish the optimal treatment algorithm for this chronic inflammatory skin condition.

Indexed as

Intense Pulsed Light TherapyLasers, DyeLow-Level Light TherapyRosaceaErythemaHumansPain MeasurementSeverity of Illness IndexTreatment Outcomeintense pulsed lightmeta‐analysispulsed‐dye laserrosaceasystematic review

Identifiers

PMID39240125
PMCPMC11626304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.